Xilio Therapeutics

Xilio Therapeutics is a biopharmaceutical company based in Waltham, Massachusetts, United States. The company is committed to transforming cancer treatment by developing tumor-selective immunotherapies that unleash the full power of potent treatments while minimizing systemic side effects. Xilio Therapeutics is building a pipeline of novel, tumor-activated molecules, including antibodies, cytokines, bispecifics, and cell engagers, with the goal of providing effective, tolerable, and durable therapeutic options for patients with solid tumors.